SynopsisAcromegaly is a disorder that results from excess growth hormone (GH) after the growth plates have closed. In this report, we study the drugs for Acromegaly. The global Acromegaly Therapeutics market was valued at US$ 2964 million in 2023 and is anticipa.....
SynopsisAcromegaly is a disorder that results from excess growth hormone (GH) after the growth plates have closed. In this report, we study the drugs for Acromegaly. The global Acromegaly Drugs market was valued at US$ 2964 million in 2023 and is anticipated to .....
SynopsisHemin is an iron-containing porphyrin with chlorine that can be formed from a haem group, such as haem b found in the haemoglobin of human blood. The global Hemin market was valued at US$ 49 million in 2023 and is anticipated to reach US$ 56 million by 2.....
SynopsisPanhematin is an iron-containing porphyrin with chlorine that can be formed from a haem group, such as haem b found in the haemoglobin of human blood. The global Panhematin market was valued at US$ 49 million in 2023 and is anticipated to reach US$ 56 mi.....
SynopsisHemin is an iron-containing porphyrin with chlorine that can be formed from a haem group, such as haem b found in the haemoglobin of human blood. The global Hemin Drugs market was valued at US$ 49 million in 2023 and is anticipated to reach US$ 56 millio.....
SynopsisPanhematin is an iron-containing porphyrin with chlorine that can be formed from a haem group, such as haem b found in the haemoglobin of human blood. The global Panhematin Drugs market was valued at US$ 49 million in 2023 and is anticipated to reach US$.....
SynopsisSwedish porphyria is a rare autosomal dominant metabolic disorder affecting the production of heme resulting from a deficiency of the porphobilinogen deaminase. It is the most common of the acute porphyrias. The global Swedish Porphyria market was valued.....
SynopsisAcute intermittent porphyria (AIP), also called Swedish porphyria, pyrroloporphyria, intermittent acute porphyria) is a rare autosomal dominant metabolic disorder affecting the production of heme resulting from a deficiency of the porphobilinogen deaminase. It.....
SynopsisAcute intermittent porphyria (AIP), also called Swedish porphyria, pyrroloporphyria, intermittent acute porphyria) is a rare autosomal dominant metabolic disorder affecting the production of heme resulting from a deficiency of the porphobilinogen deaminase. It.....
SynopsisAcute intermittent porphyria (AIP), also called Swedish porphyria, pyrroloporphyria, intermittent acute porphyria) is a rare autosomal dominant metabolic disorder affecting the production of heme resulting from a deficiency of the porphobilinogen deaminase. It.....
